Austin Px

Articles

As molecules grow more complex, drug developers in the pharma landscape face an increasing number of challenges in formulation, manufacturability, and sustainability. Fortunately, novel formulation strategies and technologies are reshaping drug development, from overcoming oral solid dose (OSD) challenges to advancing bioavailability and redefining traditional drug-likeness criteria. 

Pushing the Boundaries: Overcoming Formulation and Manufacturing Challenges in Today's Pharmaceutical Development Landscape 

The KinetiSol® Technology: Disrupting the Solid Amorphous Dispersion Landscape

to provide an overview of AustinPx, the company's bioavailability offerings, and KinetiSol technology, which represents a major breakthrough in amorphous dispersions. Learn more about:

How AustinPx was created and the strategy behind taking a technology company and turning it into a CDMO;

The origin of KinetiSol and how it can provide a faster, broader, and greener technology for amorphous solid dispersions;

How KinetiSol can alleviate challenges associated with spray drying.

Videos

Elizabeth Hickman (Chief Business Officer, AustinPx) explains the company's approach to improving bioavailability, highlighting KinetiSol technology.